Scientists have recorded major breakthrough on resistance of malaria parasite to current treatment, Artemisinin-based Combination Therapies (ACTs), with the discovery of a new non-artemisinin combination in a Phase 2b study.
Chukwuma Muanya
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business